SpectraCure ABOSTO:SPEC +2.03% Gross Margin % is 0.00% as of Mar. 2026. The stock has 1 warning sign investors should review. Among 805 Medical Devices & Instruments companies, SpectraCure AB ranks worse than 124223.48% on this metric.
The historical rank and industry rank for SpectraCure AB's Gross Margin % or its related term are showing as below:
During the past 12 years, the highestGross Margin % of SpectraCure AB was 757.80%. The lowest was 699.61%. And the median was 728.71%.
OSTO:SPEC's Gross Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 52.07 * Ranked among companies with meaningful Gross Margin % only.
SpectraCure AB had a gross margin of % for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for SpectraCure AB was 0.00% per year.
SpectraCure AB (OSTO:SPEC) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
SpectraCure AB had a gross margin of % for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
SpectraCure AB Gross Margin % Related Terms
SpectraCure AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for SpectraCure AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:SPEC vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, SpectraCure AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SpectraCure AB Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SpectraCure AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where SpectraCure AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
SpectraCure AB (OSTO:SPEC) has a Gross Margin % of 0.00% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on SpectraCure AB and its competitors. Over the past decade, SpectraCure AB's Gross Margin % has ranged from 699.61 to 757.80. According to the industry distribution chart, SpectraCure AB ranks #999999 out of 805 companies in the Medical Devices & Instruments industry.
Is SpectraCure AB's Gross Margin % too high?
SpectraCure AB's current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 699.61 to a high of 757.80. Based on the distribution chart, SpectraCure AB ranks #999999 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does SpectraCure AB's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, SpectraCure AB ranks #999999 out of 805 companies for Gross Margin %. This places SpectraCure AB in the lower half of its industry. The industry median Gross Margin % is 52.07. Historically, SpectraCure AB's own Gross Margin % has ranged from 699.61 to 757.80 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on SpectraCure AB and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SpectraCure AB's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SpectraCure AB stock overvalued right now?
SpectraCure AB (OSTO:SPEC) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For SpectraCure AB (OSTO:SPEC), the current Gross Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SPEC has been successfully added to your 